These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tissue microarrays in drug discovery. Sauter G; Simon R; Hillan K Nat Rev Drug Discov; 2003 Dec; 2(12):962-72. PubMed ID: 14654795 [No Abstract] [Full Text] [Related]
23. [Microarray and research of Chinese medications: pharmcogenomics of Chinese medications]. Jing ZW; Wang Z; Gao SH; Wang YY Zhongguo Zhong Yao Za Zhi; 2007 Feb; 32(4):289-92. PubMed ID: 17455458 [TBL] [Abstract][Full Text] [Related]
24. Drug discovery in reverse. Smith C Nature; 2004 Mar; 428(6979):227. PubMed ID: 15014516 [No Abstract] [Full Text] [Related]
25. Pharmacogenetics using Luminex® xMAP® technology: a method for developing a custom multiplex single nucleotide polymorphism mutation assay. Spierings G; Dunbar SA Methods Mol Biol; 2013; 1015():115-26. PubMed ID: 23824852 [TBL] [Abstract][Full Text] [Related]
26. Representational oligonucleotide microarray analysis (ROMA) in pharmacogenomics. Liu ET Pharmacogenomics J; 2004; 4(2):74-6. PubMed ID: 15042143 [No Abstract] [Full Text] [Related]
27. Pharmacogenomics in the preclinical development of vaccines: evaluation of efficacy and systemic toxicity in the mouse using array technology. Regnström KJ Methods Mol Biol; 2008; 448():447-67. PubMed ID: 18370242 [TBL] [Abstract][Full Text] [Related]
30. Single nucleotide polymorphism typing on DNA array with hydrophobic surface fabricated by plasma-polymerization technique. Miyachi H; Ikebukuro K; Yano K; Aburatani H; Karube I Biosens Bioelectron; 2004 Sep; 20(2):184-9. PubMed ID: 15308220 [TBL] [Abstract][Full Text] [Related]
31. Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches. Yengi LG Pharmacogenomics; 2005 Mar; 6(2):185-92. PubMed ID: 15882137 [TBL] [Abstract][Full Text] [Related]
32. ArrayFusion: a web application for multi-dimensional analysis of CGH, SNP and microarray data. Yang TP; Chang TY; Lin CH; Hsu MT; Wang HW Bioinformatics; 2006 Nov; 22(21):2697-8. PubMed ID: 16935928 [TBL] [Abstract][Full Text] [Related]
33. Gene array screening for identification of drugs with low levels of adverse side effects. Bolt HM; Marchan R; Hengstler JG Arch Toxicol; 2010 Apr; 84(4):253-4. PubMed ID: 20229237 [No Abstract] [Full Text] [Related]
35. Human inter-individual DNA sequence variation in candidate genes, drug targets, the importance of haplotypes and pharmacogenomics. Hoehe MR; Timmermann B; Lehrach H Curr Pharm Biotechnol; 2003 Dec; 4(6):351-78. PubMed ID: 14683431 [TBL] [Abstract][Full Text] [Related]
36. DNA microarrays in drug discovery and development. Debouck C; Goodfellow PN Nat Genet; 1999 Jan; 21(1 Suppl):48-50. PubMed ID: 9915501 [TBL] [Abstract][Full Text] [Related]